table of content
1 Introduction to Research & Analysis Reports
1.1 Predictive and Presymptomatic Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Predictive and Presymptomatic Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Predictive and Presymptomatic Testing Overall Market Size
2.1 Global Predictive and Presymptomatic Testing Market Size: 2022 VS 2030
2.2 Global Predictive and Presymptomatic Testing Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Predictive and Presymptomatic Testing Players in Global Market
3.2 Top Global Predictive and Presymptomatic Testing Companies Ranked by Revenue
3.3 Global Predictive and Presymptomatic Testing Revenue by Companies
3.4 Top 3 and Top 5 Predictive and Presymptomatic Testing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Predictive and Presymptomatic Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Predictive and Presymptomatic Testing Players in Global Market
3.6.1 List of Global Tier 1 Predictive and Presymptomatic Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Predictive and Presymptomatic Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Predictive and Presymptomatic Testing Market Size Markets, 2022 & 2030
4.1.2 Presymptomatic Testing
4.1.3 Predispositional Testing
4.2 By Type - Global Predictive and Presymptomatic Testing Revenue & Forecasts
4.2.1 By Type - Global Predictive and Presymptomatic Testing Revenue, 2018-2023
4.2.2 By Type - Global Predictive and Presymptomatic Testing Revenue, 2023-2030
4.2.3 By Type - Global Predictive and Presymptomatic Testing Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Predictive and Presymptomatic Testing Market Size, 2022 & 2030
5.1.2 Breast and Ovarian Cancer
5.1.3 Colorectal Cancer
5.1.4 Alzheimer's Disease
5.1.5 Multiple Endocrine Neoplasia Type 2
5.1.6 Haemochromatosis
5.2 By Application - Global Predictive and Presymptomatic Testing Revenue & Forecasts
5.2.1 By Application - Global Predictive and Presymptomatic Testing Revenue, 2018-2023
5.2.2 By Application - Global Predictive and Presymptomatic Testing Revenue, 2023-2030
5.2.3 By Application - Global Predictive and Presymptomatic Testing Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Predictive and Presymptomatic Testing Market Size, 2022 & 2030
6.2 By Region - Global Predictive and Presymptomatic Testing Revenue & Forecasts
6.2.1 By Region - Global Predictive and Presymptomatic Testing Revenue, 2018-2023
6.2.2 By Region - Global Predictive and Presymptomatic Testing Revenue, 2023-2030
6.2.3 By Region - Global Predictive and Presymptomatic Testing Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Predictive and Presymptomatic Testing Revenue, 2018-2030
6.3.2 US Predictive and Presymptomatic Testing Market Size, 2018-2030
6.3.3 Canada Predictive and Presymptomatic Testing Market Size, 2018-2030
6.3.4 Mexico Predictive and Presymptomatic Testing Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Predictive and Presymptomatic Testing Revenue, 2018-2030
6.4.2 Germany Predictive and Presymptomatic Testing Market Size, 2018-2030
6.4.3 France Predictive and Presymptomatic Testing Market Size, 2018-2030
6.4.4 U.K. Predictive and Presymptomatic Testing Market Size, 2018-2030
6.4.5 Italy Predictive and Presymptomatic Testing Market Size, 2018-2030
6.4.6 Russia Predictive and Presymptomatic Testing Market Size, 2018-2030
6.4.7 Nordic Countries Predictive and Presymptomatic Testing Market Size, 2018-2030
6.4.8 Benelux Predictive and Presymptomatic Testing Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Predictive and Presymptomatic Testing Revenue, 2018-2030
6.5.2 China Predictive and Presymptomatic Testing Market Size, 2018-2030
6.5.3 Japan Predictive and Presymptomatic Testing Market Size, 2018-2030
6.5.4 South Korea Predictive and Presymptomatic Testing Market Size, 2018-2030
6.5.5 Southeast Asia Predictive and Presymptomatic Testing Market Size, 2018-2030
6.5.6 India Predictive and Presymptomatic Testing Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Predictive and Presymptomatic Testing Revenue, 2018-2030
6.6.2 Brazil Predictive and Presymptomatic Testing Market Size, 2018-2030
6.6.3 Argentina Predictive and Presymptomatic Testing Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Predictive and Presymptomatic Testing Revenue, 2018-2030
6.7.2 Turkey Predictive and Presymptomatic Testing Market Size, 2018-2030
6.7.3 Israel Predictive and Presymptomatic Testing Market Size, 2018-2030
6.7.4 Saudi Arabia Predictive and Presymptomatic Testing Market Size, 2018-2030
6.7.5 UAE Predictive and Presymptomatic Testing Market Size, 2018-2030
7 Players Profiles
7.1 23andMe, Inc.
7.1.1 23andMe, Inc. Corporate Summary
7.1.2 23andMe, Inc. Business Overview
7.1.3 23andMe, Inc. Predictive and Presymptomatic Testing Major Product Offerings
7.1.4 23andMe, Inc. Predictive and Presymptomatic Testing Revenue in Global Market (2018-2023)
7.1.5 23andMe, Inc. Key News
7.2 Abbott Molecular, Inc.
7.2.1 Abbott Molecular, Inc. Corporate Summary
7.2.2 Abbott Molecular, Inc. Business Overview
7.2.3 Abbott Molecular, Inc. Predictive and Presymptomatic Testing Major Product Offerings
7.2.4 Abbott Molecular, Inc. Predictive and Presymptomatic Testing Revenue in Global Market (2018-2023)
7.2.5 Abbott Molecular, Inc. Key News
7.3 BioAxis DNA Research Centre Private Limited
7.3.1 BioAxis DNA Research Centre Private Limited Corporate Summary
7.3.2 BioAxis DNA Research Centre Private Limited Business Overview
7.3.3 BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Major Product Offerings
7.3.4 BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Revenue in Global Market (2018-2023)
7.3.5 BioAxis DNA Research Centre Private Limited Key News
7.4 Color Genomics, Inc.
7.4.1 Color Genomics, Inc. Corporate Summary
7.4.2 Color Genomics, Inc. Business Overview
7.4.3 Color Genomics, Inc. Predictive and Presymptomatic Testing Major Product Offerings
7.4.4 Color Genomics, Inc. Predictive and Presymptomatic Testing Revenue in Global Market (2018-2023)
7.4.5 Color Genomics, Inc. Key News
7.5 Direct Laboratory Services LLC (DirectLabs)
7.5.1 Direct Laboratory Services LLC (DirectLabs) Corporate Summary
7.5.2 Direct Laboratory Services LLC (DirectLabs) Business Overview
7.5.3 Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Major Product Offerings
7.5.4 Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Revenue in Global Market (2018-2023)
7.5.5 Direct Laboratory Services LLC (DirectLabs) Key News
7.6 Gene by Gene Ltd.
7.6.1 Gene by Gene Ltd. Corporate Summary
7.6.2 Gene by Gene Ltd. Business Overview
7.6.3 Gene by Gene Ltd. Predictive and Presymptomatic Testing Major Product Offerings
7.6.4 Gene by Gene Ltd. Predictive and Presymptomatic Testing Revenue in Global Market (2018-2023)
7.6.5 Gene by Gene Ltd. Key News
7.7 Genomic Diagnostics
7.7.1 Genomic Diagnostics Corporate Summary
7.7.2 Genomic Diagnostics Business Overview
7.7.3 Genomic Diagnostics Predictive and Presymptomatic Testing Major Product Offerings
7.7.4 Genomic Diagnostics Predictive and Presymptomatic Testing Revenue in Global Market (2018-2023)
7.7.5 Genomic Diagnostics Key News
7.8 Mapmygenome
7.8.1 Mapmygenome Corporate Summary
7.8.2 Mapmygenome Business Overview
7.8.3 Mapmygenome Predictive and Presymptomatic Testing Major Product Offerings
7.8.4 Mapmygenome Predictive and Presymptomatic Testing Revenue in Global Market (2018-2023)
7.8.5 Mapmygenome Key News
7.9 Myriad Genetics, Inc.
7.9.1 Myriad Genetics, Inc. Corporate Summary
7.9.2 Myriad Genetics, Inc. Business Overview
7.9.3 Myriad Genetics, Inc. Predictive and Presymptomatic Testing Major Product Offerings
7.9.4 Myriad Genetics, Inc. Predictive and Presymptomatic Testing Revenue in Global Market (2018-2023)
7.9.5 Myriad Genetics, Inc. Key News
7.10 Pathway Genomics Corporation
7.10.1 Pathway Genomics Corporation Corporate Summary
7.10.2 Pathway Genomics Corporation Business Overview
7.10.3 Pathway Genomics Corporation Predictive and Presymptomatic Testing Major Product Offerings
7.10.4 Pathway Genomics Corporation Predictive and Presymptomatic Testing Revenue in Global Market (2018-2023)
7.10.5 Pathway Genomics Corporation Key News
7.11 Positive Bioscience, Inc.
7.11.1 Positive Bioscience, Inc. Corporate Summary
7.11.2 Positive Bioscience, Inc. Business Overview
7.11.3 Positive Bioscience, Inc. Predictive and Presymptomatic Testing Major Product Offerings
7.11.4 Positive Bioscience, Inc. Predictive and Presymptomatic Testing Revenue in Global Market (2018-2023)
7.11.5 Positive Bioscience, Inc. Key News
7.12 Quest Diagnostics, Inc.
7.12.1 Quest Diagnostics, Inc. Corporate Summary
7.12.2 Quest Diagnostics, Inc. Business Overview
7.12.3 Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Major Product Offerings
7.12.4 Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Revenue in Global Market (2018-2023)
7.12.5 Quest Diagnostics, Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
